{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:52:29Z","timestamp":1773712349702,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.625326\/2021-00"],"award-info":[{"award-number":["88887.625326\/2021-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["565412\/2014-9"],"award-info":[{"award-number":["565412\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50873-3"],"award-info":[{"award-number":["2014\/50873-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/19823-0"],"award-info":[{"award-number":["2018\/19823-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.psychres.2023.115402","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T15:43:52Z","timestamp":1690904632000},"page":"115402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Plasma levels of neurotrophin 4\/5, NGF and pro-BDNF influence transition to mental disorders in a sample of individuals at ultra-high risk for psychosis"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0006-8107","authenticated-orcid":false,"given":"Alexandre Andrade","family":"Loch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4323-3690","authenticated-orcid":false,"given":"Marcel Tavares Camilo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio Cesar","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Peroni","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4213-4790","authenticated-orcid":false,"given":"Matheus Wanderley","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-8108","authenticated-orcid":false,"given":"Natalia Mansur","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martinus Theodorus van de","family":"Bilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda Leme","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Farid","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115402_bib0001","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(02)00757-8","article-title":"Stress and nerve growth factor: Findings in animal models and humans","volume":"73","author":"Aloe","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2023.115402_bib0002","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.euroneuro.2008.07.008","article-title":"Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers","volume":"18","author":"Angelucci","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115402_bib0003","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2018.08.005","article-title":"In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present","volume":"684","author":"Arabska","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2023.115402_bib0004","first-page":"149","article-title":"Stress effects on BDNF expression: Effects of age, sex, and form of stress","volume":"239","author":"Bath","year":"2013","journal-title":"Neuroscience, Steroid hormone actions in the CNS: the role of brain-derived neurotrophic factor (BDNF)"},{"key":"10.1016\/j.psychres.2023.115402_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2011.04.003","article-title":"Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia","volume":"94","author":"Bellon","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psychres.2023.115402_bib0006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2019.11.010","article-title":"Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease","volume":"87","author":"Bharani","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.psychres.2023.115402_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.01.025","article-title":"Neurotrophins and schizophrenia","volume":"94","author":"Buckley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0008","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/187152711796235032","article-title":"A Dual Mechanism Linking NGF\/proNGF Imbalance and Early Inflammation to Alzheimer's Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model","volume":"10","author":"Capsoni","year":"2011","journal-title":"CNS Neurol. Disord. - Drug Targets- CNS Neurol. Disord."},{"key":"10.1016\/j.psychres.2023.115402_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2010.06.012","article-title":"Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia","volume":"45","author":"Carlino","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jamapsychiatry.2021.1290","article-title":"Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis","volume":"78","author":"Catalan","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jnr.23863","article-title":"Sex differences in brain-derived neurotrophic factor signaling and functions","volume":"95","author":"Chan","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.psychres.2016.10.012","article-title":"Tobacco use is associated with increased plasma BDNF levels in depressed patients","volume":"246","author":"Colle","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2023.115402_bib0013","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1007\/s12035-017-0505-7","article-title":"PROneurotrophins and CONSequences","volume":"55","author":"Costa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psychres.2023.115402_bib0014","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1590\/1516-4446-2021-2056","article-title":"Translation and validation of the Structured Interview for Prodromal Syndromes (SIPS) to Portuguese","volume":"43","author":"Diniz","year":"2021","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1192\/bjp.164.5.630","article-title":"South Westminster Schizophrenia Survey: Alcohol use and Its Relationship to Symptoms, Tardive Dyskinesia and Illness Onset","volume":"164","author":"Duke","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.biopsych.2005.04.014","article-title":"Suicide Brain Is Associated with Decreased Expression of Neurotrophins","volume":"58","author":"Dwivedi","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0017","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1440-1681.2008.04904.x","article-title":"Chronic Mental Stress Is a Cause of Essential Hypertension: Presence of Biological Markers of Stress","volume":"35","author":"Esler","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.psychres.2023.115402_bib0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/mcne.2001.1016","article-title":"The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease","volume":"18","author":"Fahnestock","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.psychres.2023.115402_bib0019","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/460543","article-title":"Cholinergic degeneration and alterations in the TrkA and p75NTR balance as a result of pro-NGF injection into aged rats","author":"Fortress","year":"2011","journal-title":"J. Aging Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2016.09.003","article-title":"Deconstructing Vulnerability for Psychosis: Meta-Analysis of Environmental Risk Factors for Psychosis in Subjects at Ultra High-Risk","volume":"40","author":"Fusar-Poli","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archgenpsychiatry.2010.132","article-title":"Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis: An Analysis of Patient-Sibling and Sibling-Control Pairs","volume":"68","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0022","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12888-014-0268-x","article-title":"Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition","volume":"14","author":"Gonzalez-Liencres","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0023","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.11.016","article-title":"Plasma protein levels of brain-derived neurotrophic factor pathways and their association with cognitive performance in patients with clinical high risk for psychosis and first episode psychosis","author":"He","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.psychres.2023.115402_bib0026","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15622975.2018.1462532","article-title":"Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients","volume":"20","author":"Heitz","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0027","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","article-title":"Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas","volume":"57","author":"Hock","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.psychres.2023.115402_bib0028","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The Dopamine Hypothesis of Schizophrenia: Version III\u2014The Final Common Pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115402_bib0029","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk Receptors: Roles in Neuronal Signal Transduction","volume":"72","author":"Huang","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.psychres.2023.115402_bib0030","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1073\/pnas.89.7.3060","article-title":"Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity","volume":"89","author":"Ip","year":"1992","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.psychres.2023.115402_bib0031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881103174007","article-title":"Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients","volume":"17","author":"Jockers-Scher\u00fcBl","year":"2003","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.psychres.2023.115402_bib0032","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijdevneu.2007.07.002","article-title":"Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls","volume":"25","author":"Katoh-Semba","year":"2007","journal-title":"Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci."},{"key":"10.1016\/j.psychres.2023.115402_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-003-0100-0","article-title":"State of the art of the neurotrophin hypothesis in psychiatric disorders: Implications and limitations","author":"Lang","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psychres.2023.115402_bib0034","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1126\/science.1065057","article-title":"Regulation of cell survival by secreted proneurotrophins","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.psychres.2023.115402_bib0035","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1007\/s12035-015-9461-2","article-title":"Serum Levels of Brain-Derived Neurotrophic Factor Are Associated with Diabetes Risk, Complications, and Obesity: a Cohort Study from Chinese Patients with Type 2 Diabetes","volume":"53","author":"Li","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psychres.2023.115402_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2021.11.011","article-title":"Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis","volume":"239","author":"Li","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0037","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0038","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.psychres.2023.115402_bib0039","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/A:1022817918651","article-title":"Neurotrophic factor effects on oxidative stress-induced neuronal death","volume":"28","author":"Lobner","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0040","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s11064-004-7040-4","article-title":"Role of MAPK\/ERK in neurotrophin-4 potentiation of necrotic neuronal death","volume":"29","author":"Lobner","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0041","first-page":"328","volume":"10","author":"Loch","year":"2019","journal-title":"Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited. Front. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0042","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.psychres.2017.03.052","article-title":"Poverty, low education, and the expression of psychotic-like experiences in the general population of S\u00e3o Paulo, Brazil","volume":"253","author":"Loch","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2023.115402_bib0043","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnpbp.2014.09.014","article-title":"Elevated neurotrophin-3 and neurotrophin 4\/5 levels in unmedicated bipolar depression and the effects of lithium","volume":"56","author":"Loch","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0044","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115402_bib0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0143-4179(02)00134-8","article-title":"Sex-related variations in serum nerve growth factor concentration in humans","volume":"36","author":"Martocchia","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psychres.2023.115402_bib0046","series-title":"Early Intervention in Psychotic Disorders, NATO Science Series","first-page":"135","article-title":"Instrument for the Assessment of Prodromal Symptoms and States","author":"McGlashan","year":"2001"},{"key":"10.1016\/j.psychres.2023.115402_bib0047","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/wps.20514","article-title":"Beyond the \u201cat risk mental state\u201d concept: transitioning to transdiagnostic psychiatry","volume":"17","author":"McGorry","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0048","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.pharep.2017.04.013","article-title":"Assessing the serum concentration levels of NT-4\/5, GPX-1, TNF-\u03b1, and l-arginine as biomediators of depression severity in first depressive episode patients with and without posttraumatic stress disorder","volume":"69","author":"Og\u0142odek","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.psychres.2023.115402_bib0049","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/mp.2016.235","article-title":"A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia","volume":"22","author":"Qin","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpsychires.2016.11.012","article-title":"Peripheral blood nerve growth factor levels in major psychiatric disorders","volume":"86","author":"Rao","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0051","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpsychires.2018.09.007","article-title":"The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis","volume":"106","author":"Rodrigues-Amorim","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2018.06.053","article-title":"Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study","volume":"268","author":"Sanada","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2023.115402_bib0053","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2020.02.009","article-title":"Individualized Diagnostic and Prognostic Models for Patients With Psychosis Risk Syndromes: A Meta-analytic View on the State of the Art","volume":"88","author":"Sanfelici","year":"2020","journal-title":"Biol. Psychiatry, Psychosis Risk Syndrome"},{"key":"10.1016\/j.psychres.2023.115402_bib0054","doi-asserted-by":"crossref","unstructured":"Shen, W., Zhu, L., Lee, S.-R., Chung, S.H., Gillies, M.C., 2013. Involvement of NT3 and P75 NTR in photoreceptor degeneration following selective M\u00fcller cell ablation. 10.1186\/1742-2094-10-137.","DOI":"10.1186\/1742-2094-10-137"},{"key":"10.1016\/j.psychres.2023.115402_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115402_bib0056","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopha.2015.10.010","article-title":"Update on the role of p75NTR in neurological disorders: A novel therapeutic target","volume":"76","author":"Shu","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.psychres.2023.115402_bib0057","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1471-4159.1998.70051859.x","article-title":"Neurotrophins rescue cerebellar granule neurons from oxidative stress- mediated apoptotic death: Selective involvement of phosphatidylinositol 3- kinase and the mitogen-activated protein kinase pathway","volume":"70","author":"Skaper","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psychres.2023.115402_bib0058","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/ijms18020268","article-title":"Integral Characterization of Defective BDNF\/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies","volume":"18","author":"Tejeda","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2023.115402_bib0059","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00406-020-01117-y","article-title":"Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-na\u00efve first-episode psychosis","volume":"270","author":"Toll","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2023.115402_bib0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainresbull.2020.11.005","article-title":"Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases","volume":"166","author":"Wang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.psychres.2023.115402_bib0061","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2015.05.067","article-title":"Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk","volume":"184","author":"Wiener","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2023.115402_bib0062","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41467-019-09744-3","article-title":"Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling","volume":"10","author":"Wong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.psychres.2023.115402_bib0063","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/08039488.2015.1087592","article-title":"Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia","volume":"70","author":"Wysoki\u0144ski","year":"2016","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0064","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ijnp\/pyy036","article-title":"Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis-findings from the longitudinal youth at risk study (LYRIKS)","volume":"21","author":"Yee","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115402_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2021.07.056","article-title":"A novel commentary: Investigation of the role of a balance between neurotrophic and apoptotic proteins in the pathogenesis of psychosis via the tPA-BDNF pathway","volume":"142","author":"Yesilkaya","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2023.115402_bib0066","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1007\/s12035-022-03054-4","article-title":"Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the \u201cBeware the Ides of March\u201d for Unaffected Relatives of Schizophrenia Patients?","volume":"59","author":"Yesilkaya","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psychres.2023.115402_bib0067","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","article-title":"Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States","volume":"39","author":"Yung","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115402_bib0068","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5498\/wjp.v12.i3.379","article-title":"Neuroimmune crosstalk through brain-derived neurotrophic factor and its precursor pro-BDNF: New insights into mood disorders","volume":"12","author":"Zhao","year":"2022","journal-title":"World J. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T20:28:30Z","timestamp":1717619310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123003529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"alternative-id":["S0165178123003529"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115402","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of neurotrophin 4\/5, NGF and pro-BDNF influence transition to mental disorders in a sample of individuals at ultra-high risk for psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115402"}}